{"id":"SEC-13-024","kind":"order","level":"federal","jurisdiction":"United States","state":"","metro":"","industry":"13","agency":"","eco":"","issuer":"Departments of Labor, Health and Human Services and the Treasury","authority":"FFCRA sec. 6001; CARES secs. 3201-3203","instrument":"FAQs About FFCRA and CARES Act Implementation Part 44","title":"FAQs Part 44","dateIssued":"2021-02-26","effective":"2021-02-26","end":"end of the PHE","startDate":"2021-02-26","endDate":"2021-09-30","quarters":["2021Q1","2021Q2","2021Q3"],"types":["OTHER","HC"],"addressees":["group health plans and health insurance issuers"],"clause":"plans and issuers must cover COVID-19 diagnostic testing for an asymptomatic individual without cost sharing, prior authorization or other medical management requirements [and] must provide coverage without cost sharing for all COVID-19 vaccines... the requirement to cover the Pfizer-BioNTech COVID-19 vaccine became effective January 5, 2021, and the requirement to cover the Moderna COVID-19 vaccine became effective January 12, 2021.","enforcement":"ERISA, the Code and the PHS Act","functions":["IN","CB"],"notes":"Confirms the mandates\u0027 operation in 2021; the HHS Secretary renewed the PHE effective Jan. 21, 2021 (recited).","sourceUrl":"https://www.dol.gov/sites/dolgov/files/EBSA/about-ebsa/our-activities/resource-center/faqs/aca-part-44.pdf","snapshot":"http://web.archive.org/web/20210318054046id_/https://www.dol.gov/sites/dolgov/files/EBSA/about-ebsa/our-activities/resource-center/faqs/aca-part-44.pdf","fileExists":true,"fileBytes":98445,"grade":"primary","character":"","description":"","collection":"SEC-13","url":"/library/SEC-13-024","exhibitUrl":"/exhibit/SEC-13-024","citation":"Departments of Labor, Health and Human Services and the Treasury, FAQs About FFCRA and CARES Act Implementation Part 44 (Feb. 26, 2021) (Ex. SEC-13-024)","stateName":"","related":[]}